NeuroRester Shrinks Clinical-Grade Recovery Tech into Wearable Coin

The system relies on two distinct modules: one dedicated to overnight rhythm support and another, labeled CardioGyms, which focuses on metabolic and vascular equilibrium. While traditional wearables primarily collect data, NeuroRester utilizes an AI engine to analyze existing metrics from third-party devices and recalibrate daily protocols in real-time. This 24-hour adaptive loop relies on a morning check-in process to evolve its output based on the user's previous night of rest.

Founder and CEO Jack Wang describes the technology as a shift from mere data visualization to actionable health routines. The underlying science stems from studies conducted at Harvard Medical School and the Mayo Clinic, which explored the link between metabolic markers and recovery quality. NeuroRester spent 15 years miniaturizing Digital Pulsed Electromagnetic Field technology—previously restricted to bulky, clinic-bound equipment—to achieve this form factor. The device, which can be worn on the wrist or ankle, will be available for early-bird access on Kickstarter in August, with general distribution slated for September 2026.